The Orofacial Infections market is a subset of the larger Therapeutic Area, which focuses on the treatment of diseases and disorders of the mouth, jaw, and face. Orofacial Infections are caused by a variety of bacteria, viruses, and fungi, and can range from mild to severe. Common symptoms include pain, swelling, and redness in the affected area. Treatment options include antibiotics, antifungals, antivirals, and other medications. In some cases, surgery may be necessary.
The Orofacial Infections market is highly competitive, with a variety of companies offering products and services. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, Novartis, and Sanofi. Other companies include Allergan, AstraZeneca, Bayer, and Eli Lilly. Show Less Read more
